KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Other Operating Expenses (2016 - 2019)

Eli Lilly's Other Operating Expenses history spans 8 years, with the latest figure at -$151.7 million for Q4 2019.

  • For Q4 2019, Other Operating Expenses rose 21.24% year-over-year to -$151.7 million; the TTM value through Sep 2020 reached -$151.7 million, up 75.39%, while the annual FY2019 figure was -$9.1 billion, 10.93% down from the prior year.
  • Other Operating Expenses reached -$151.7 million in Q4 2019 per LLY's latest filing, up from -$423.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.0 billion in Q4 2016 to a low of -$423.9 million in Q1 2019.
  • Average Other Operating Expenses over 5 years is $220.6 million, with a median of -$57.4 million recorded in 2016.
  • Peak YoY movement for Other Operating Expenses: surged 3526.71% in 2016, then crashed 793.41% in 2017.
  • A 5-year view of Other Operating Expenses shows it stood at -$144.9 million in 2015, then soared by 3526.71% to $5.0 billion in 2016, then tumbled by 100.89% to -$44.4 million in 2017, then tumbled by 333.78% to -$192.6 million in 2018, then increased by 21.24% to -$151.7 million in 2019.
  • Per Business Quant, the three most recent readings for LLY's Other Operating Expenses are -$151.7 million (Q4 2019), -$423.9 million (Q1 2019), and -$192.6 million (Q4 2018).